Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10874526 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Temporarily not available Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
Conditions: Infection, Soft Tissue;   Infection, Wound;   Cellulitis;   Diabetic Foot Ulcer
Interventions: Drug: Cefazolin;   Device: Silberg Tissue Preparation System

Study has passed its completion date and status has not been verified in more than two years.